These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364 [TBL] [Abstract][Full Text] [Related]
11. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia. Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854 [TBL] [Abstract][Full Text] [Related]
12. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Spindler C; Ortqvist A Eur Respir J; 2006 Oct; 28(4):816-23. PubMed ID: 16737983 [TBL] [Abstract][Full Text] [Related]
13. Optimal therapy for severe pneumococcal community-acquired pneumonia. Luján M; Gallego M; Rello J Intensive Care Med; 2006 Jul; 32(7):971-80. PubMed ID: 16791660 [TBL] [Abstract][Full Text] [Related]
14. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association]. Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863 [No Abstract] [Full Text] [Related]
15. [Pulmonary infections]. Rohde G Dtsch Med Wochenschr; 2011 Dec; 136(48):2486-8. PubMed ID: 22109582 [No Abstract] [Full Text] [Related]
16. Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-acquired pneumonia. Singer M; Nambiar S; Valappil T; Higgins K; Gitterman S Clin Infect Dis; 2008 Dec; 47 Suppl 3():S216-24. PubMed ID: 18986293 [TBL] [Abstract][Full Text] [Related]
17. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia]. Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672 [TBL] [Abstract][Full Text] [Related]